Induction of Immune Response by Hepatitis B virus Core Protein in a Mouse Model
Date Issued
2014
Date
2014
Author(s)
Tzeng, Horng-Tay
Abstract
Persistent hepatitis B viral (HBV) infection results in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Recent studies in animal models of viral infection indicate that the interaction between the inhibitory receptor, programmed death (PD)-1, on lymphocytes and its ligand (PD-L1) play a critical role in T-cell exhaustion by inducing T-cell inactivation. We studied T-cell exhaustion and the effects of PD-1 and PD-L1 blockade on intrahepatic infiltrating T-cells in our recently developed mouse model of HBV persistence. In this mouse animal model, we demonstrated that the chronicity of hepatitis B virus infection was associated with PD-1 expression on intrahepatic lymphocytes. The Intrahepatic CD8+ T-cells expressed higher levels of PD-1 and lower levels of CD127 in carrier mice. Blockade of PD-1/PD-L1 interactions by an anti-PD-1 monoclonal antibody (mAb) increased HBcAg-specific interferon (IFN)-γ production in intrahepatic T lymphocytes and reversed the exhausted phenotype in intrahepatic T lymphocytes and viral persistence to clearance of HBV in vivo. Our results indicated that PD-1 blockage reverses immune dysfunction and viral persistence of HBV infection in a mouse animal model, suggesting that the anti-PD-1 mAb might be a good therapeutic candidate for chronic HBV infection.
An efficient control of virus infections requires the coordinated actions of both innate and adaptive immune responses. In order to define the role of innate immunity effectors against HBV, viral clearance was studied in a panel of immunodeficient mouse strains. Our results demonstrate that HBV viral clearance is not changed in IFN-α/β receptor (IFNAR), RIG-I, MDA5, MYD88, NLRP3, ASC, and IL-1R knockout mice. In contrast, HBV persists in the absence of tumor necrosis factor-alpha (TNF-α) or in mice treated with the soluble TNF receptor blocker, Etanercept. In these mice, there was an increase in PD-1-expressing CD8+ T-cells and an increase of serum HBV DNA, HBV core, and surface antigen expression as well as viral replication within the liver. Furthermore, the induction of TNF-α in clearing HBV is dependent on the HBV core, and TNF blockage eliminated HBV core-induced viral clearance effects. Finally, the intra-hepatic leukocytes (IHLs), but not the hepatocytes, are the cell source responsible for TNF-α production induced by HBcAg. These results provide evidences for TNF-α mediated innate immune mechanisms in HBV clearance and explain the mechanism of HBV reactivation during therapy with TNF blockage agents.
Subjects
B型肝炎病毒
PD-1阻斷
病毒持續性
先天免疫力
腫瘤壞死因子
SDGs
Type
thesis
File(s)![Thumbnail Image]()
Loading...
Name
ntu-103-D96449003-1.pdf
Size
23.32 KB
Format
Adobe PDF
Checksum
(MD5):5dd604dd15148348a39b56adefb7f2b9